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 Schizophrenia is currently conceptualized as a neurodevelopmental disorder in 
which subtle brain dysmaturation is expressed across a continuum of impairment referred 
to as schizotypy.  Recently, schizophrenia researchers have attempted to identify markers 
that are present during all stages of the illness, as well as in subclinical manifestations of 
the disorder.  The discovery of markers for schizophrenia should enhance our knowledge 
about the etiology and development of the disorder, as well as facilitate the identification 
of individuals at increased risk for developing the disorder.  Neuropsychological 
impairment has long been recognized as a central feature of schizophrenia.  Furthermore, 
neuropsychological impairment has been purported to be present before the onset of 
schizophrenia and indicative of liability for the disorder.  The present study examined the 
relationship of attention, executive functioning, and memory with ratings of positive and 
negative schizotypy in a sample of 156 college students.  Results indicated that positive 
schizotypy was associated with neuropsychological deficits, above and beyond the 
variance associated with intellectual functioning and general psychological distress.  
Surprisingly, negative schizotypy was not related to impaired neuropsychological 
performance.
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CHAPTER I 
INTRODUCTION 
The present study examined the relationship between neuropsychological 
functioning and the positive and negative symptom dimensions of schizotypy.  
Neuropsychological impairment is widely described as a central feature of schizophrenia 
and related disorders, and it is hypothesized that this impairment will also be associated 
with nonpsychotic manifestations of vulnerability to schizophrenia.  It is specifically 
hypothesized that neuropsychological impairment will be inversely correlated with 
ratings of positive and negative schizotypy. In addition, consistent with findings in 
samples of patients with schizophrenia, it is predicted that negative symptoms of 
schizotypy will be more strongly related to neuropsychological impairment than the 
positive symptoms of schizotypy. 
Schizophrenia and Schizotypy 
Schizophrenia appears to be best conceptualized as a neurodevelopmental brain 
disorder.  Current models of the etiology of schizophrenia (e.g., Meehl, 1989; Gottesman, 
1991; Andreason, 1999) assume that there are schizophrenia-prone, or “schizotypic,” 
individuals who are vulnerable to developing schizophrenia and related disorders.  While 
the exact mechanisms are not fully understood, this vulnerability is presumed to result 
from an accumulation or interaction of multiple genetic, neurodevelopmental, and 
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psychosocial factors or hits.  These risk factors produce a continuum of schizophrenia-
like adjustment that has been referred to as schizotypy.  It is hypothesized that the 
majority of schizotypic individuals will not decompensate into psychosis, although they 
may experience attenuated or transient symptoms of schizophrenia.  These symptoms fall 
on a continuum from relatively healthy to subclinical deviance to schizophrenia-spectrum 
personality disorders to full blown psychosis.  Thus, schizotypy is expressed across a 
dynamic continuum of adjustment with severity contingent on the interaction of 
biopsychosocial factors (Gooding & Iacono, 1995). 
Schizotypy has been described as a multidimensional construct consisting of two 
or more factors.  Consistent with multidimensional models of schizophrenia, candidate 
factors include positive symptom schizotypy, negative symptom schizotypy, cognitive 
disorganization, paranoia, and nonconformity (e.g., Raine et al., 1994; Claridge et al., 
1996; Vollema & van den Bosch, 1995; Mason, Claridge, & Williams, 1997; Stefanis et 
al., 2002).  Positive and negative symptom schizotypy are the most consistently 
replicated factors.  While there is not a universally agreed upon latent structure of 
schizotypy, the proposed factors appear to be consistent with those hypothesized to 
comprise schizophrenia, such as positive, negative, and disorganized dimensions (e.g., 
Bilder, Mukherjee, Rieder, & Pandurangi, 1985; Liddle, 1987; Arndt, Alliger, & 
Andreason, 1991; Peralta, Cuesta, & de Leon, 1992).  This parallel structure adds 
empirical support to the hypothesis that the biological/genetic vulnerability to 
schizophrenia is expressed across the continuum of schizotypy.  Positive symptoms of 
schizophrenia include excesses in behavior, such as hallucinations and delusions, while 
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negative symptoms refer to deficits in behavior, such as loss of volition, social 
withdrawal, and flattened affect.  Positive and negative symptom schizotypy appear to 
reflect milder and non-psychotic manifestations of the symptoms seen in schizophrenia. 
The reliable identification of markers of schizotypy and schizotypic individuals 
should improve our understanding of the etiology of schizophrenia and facilitate the 
development of prophylactic treatment interventions.  Psychometric scales with 
established validity and reliability have been developed to assist in the identification of 
schizotypy.  Although there are alternative methods of assessing risk for schizophrenia, 
such as identifying relatives of individuals with schizophrenia, or examining individuals 
with related disorders (e.g., paranoid, schizotypal, and schizoid personality disorders), 
Lenzenweger (1998) noted several advantages of the psychometric method.  Perhaps the 
greatest advantage is that psychometric measures can be used to screen large numbers of 
individuals from the general population in a very time-efficient manner.  They also tend 
to be relatively non-invasive and inexpensive to administer and score.  Finally, they can 
be used in conjunction with other measures of risk, including family studies, which has 
been demonstrated by research such as the New York High Risk Project (e.g., 
Erlenmeyer-Kimling et al., 1992).  The present study focuses on the use of symptom and 
trait-based screening measures in conjunction with a battery of neuropsychological tests.  
It is proposed that neuropsychological impairment in the at-risk population may help us 
make sense of the variability that characterizes schizophrenia. 
The heterogeneity of schizophrenia has created limitations for researchers 
studying the etiology, development, and treatment of this disorder.  The phenotypic 
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variation exhibited by patients with schizophrenia has made it challenging for 
investigators trying to identify relevant etiological and developmental factors.  Moreover, 
the changes that are associated with the onset of this disorder, such as medication, 
hospitalization, social stigma, and drug abuse make it difficult to disentangle the factors 
that are etiologically relevant to the disorder from those that are consequences of the 
disorder.  As a result, investigators have begun to look for characteristics that may be 
present in individuals at-risk for the schizophrenia and related conditions.  This strategy 
minimizes confounds associated with the onset of the schizophrenia and also allows for 
the possibility of discovering underlying traits that occur in the premorbid, acute, and 
residual phases of the disorder.   
Neuropsychological Impairment as a Marker of Risk 
Ever since Kraeplin (1919) used the term dementia praecox to describe the 
disease we now call schizophrenia, there has been recognition that neuropsychological 
impairment is a hallmark of the disorder.  If neuropsychological impairment is 
representative of vulnerability for schizophrenia, it should be evident during all stages of 
the disorder, including those individuals at-risk for schizophrenia.  Consistent with the 
neurodevelopmental model of schizophrenia, neuropsychological impairment has been 
found in milder degrees in at-risk samples (e.g., Byrne, Hodges, Grant, Owens, & 
Johnstone, 1999; Cornblatt, Obuchowski, Roberts, Pollack, & Erlenmeyer-Kimling 1999; 
Cadenhead, Perry, Shafer, & Braff, 1999; Suhr, 1997).  Thus, it appears that mild 
neuropsychological deficits may be evident before schizophrenia develops and indicative 
of increased risk for the disorder.  These deficits may also be etiologically related to the 
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development of schizophrenia.  For example, underactivity and dysregulation of frontal 
lobe functioning might lead to avolition, a feature of schizophrenia that can be measured 
with executive functioning tasks.  In addition, hippocampal abnormalities may play a role 
in the development of schizophrenia and manifest as mild memory deficits before the 
onset of schizophrenia.  
Trying to link neuropsychological impairment to the vulnerability for 
schizophrenia before the onset of clinical psychosis has many advantages.  Most 
importantly, if areas of impairment can be reliably defined in individuals at-risk for the 
disorder, geneticists, pharmacologists, and other researchers trying to pinpoint the 
biological underpinnings of the disorder can examine more homogeneous populations.  
Further insights into the specific pathology, the processes responsible for conferring 
liability, and the temporal sequence of neuropsychological and symptomatic change 
should help us better understand the etiological roots that lead to the vulnerability for and 
development of schizophrenia.  These findings should facilitate the development of 
treatment interventions, perhaps even prophylactic treatments.  The following section will 
review the major areas of neuropsychological functioning that are typically measured 
when assessing for neuropsychological impairment. 
Neuropsychological Constructs 
 Studies of neuropsychological functioning in individuals at-risk for schizophrenia 
have typically examined one or more of the following constructs:  1) Attention; 2) 
Executive functioning; and 3) Memory.   
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Attention.  Mirsky et al. (1991) used factor analysis to derive four components of 
attention.  These components of attention have been replicated by five independent 
research teams (Kendler et al., 1991; Kremen, Seidman, Faraone, Pepple, & Tsuang, 
1992; Pogge, Stokes, & Harvey, 1994; Steinhauer et al., 1991; Tatman, 1992).  The first 
factor of attention, “Focus/Execute,” measures the capacity to focus on and scan stimuli, 
as well as quickly execute responses.  According to Mirsky, this aspect of attention can 
be assessed with tests like the Stroop Color and Word Test (Golden, 1978), the Trail 
Making Test (Reitan, 1958), and the Digit Symbol-Coding subtest from the Wechsler 
Adult Intelligence Scale-Third Edition (WAIS-III; Wechsler, 1997).  The second factor 
of attention, “Sustain,” involves the capacity to maintain focus of attention and is 
measured with sustained vigilance or continuous performance tests.  This component 
differs from the Focus/Execute component in that there is limited scanning of stimuli and 
more of a demand for prolonged vigilance.  The third component of attention, “Shift”, is 
the capacity to shift attentional focus from one stimulus to another in a flexible manner 
and can be measured by tasks like the Wisconsin Card Sorting Task (WCST; Heaton, 
Chelune, Talley, Kay, & Curtis, 1993), which are also used to assess one component of 
executive functioning.  The final attentional factor, “Encoding,” is the capacity to use 
attention for encoding purposes.  This aspect of attention assesses an individual’s ability 
to serially incorporate, manipulate, store, and recall information and can be measured by 
tasks like the Arithmetic and Digit Span subtests from the WAIS-III (Mirsky, 1988, 
1989; Mirsky et al., 1991).   
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Despite evidence that attention is a multidimensional construct, most 
investigations in the schizotypy or at-risk literature have only examined the sustain 
component as measured by the Continuous Performance Test-Identical Pairs (CPT-IP; 
Cornblatt & Erlenmeyer-Kimling, 1985; Erlenmeyer-Kimling & Cornblatt, 1992) or the 
Degraded Stimulus-Continuous Performance Test (Nuechterlein, 1983; Nuechterlein & 
Asarnow, 1997).  Studies investigating CPT-IP performance and other measures of 
attention in at-risk samples have yielded mixed results (Lenzenweger, 2001; Obiols, 
Garcia-Domingo, de Trincheria, & Domenech, 1993; Laurent et al. 1999; Rybakowski & 
Borkowska, 2002; Cadenhead et al., 1999; Laurent et al., 2000; Keefe et al., 1994; Byrne 
et al., 1999; Cosway et al., 2002; Laurent et al., 2002; Rybakowski & Borkowska, 2002; 
Keefe et al., 1994). 
 Executive functioning.  Executive functioning describes several higher-order 
cognitive processes, such as the integration of multimodal sensory input, generation of 
multiple response alternatives, maintenance of set and goal-directed behaviors, adaptation 
to changes in environment, planning abilities, and self-evaluation (Stuss & Benson, 1986; 
Dubios et al., 1994).  Lezak (1995) conceptualizes executive functions as comprising four 
components: 1) volition; 2) planning; 3) purposive action; and 4) effective performance.  
According to Lezak, these subcomponents of executive functioning measure the ability to 
determine wants and needs, generate alternatives, formulate and carry out goals, inhibit 
impulses, and monitor performance.  Lezak also describes conceptual functions, which 
are characterized by mental flexibility and abstract thinking.  Many other researchers 
have classified conceptual functions as falling under the rubric of executive functioning.   
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Similar to the literature on attentional functioning, most investigations of 
executive functioning utilize one task (the WCST) as a representation of executive 
functioning.  Based upon a review of the literature, there are additional tests that measure 
this multifaceted component of neuropsychological functioning, including the Mazes 
subtest from the Wechsler Intelligence Scale for Children-Third Edition (WISC-III; 
Wechsler, 1991), the Tower of London (Shallice, 1982) and Toronto (Saint Cyr & 
Taylor, 1992) tasks, the Ruff Figural Fluency Test (Ruff, 1996), the Controlled Oral 
Word Association Test (Spreen & Strauss, 1991) and the Stroop Color and Word Test. 
 Also similar to the literature on attentional functioning, an inconsistent pattern of 
impairment has been reported regarding executive functioning in individuals at-risk for 
schizophrenia.  Several studies have reported significant differences (Faraone et al., 1999; 
Laurent et al., 2001; Rybakowski & Borkowska, 2002; Wolf, Cornblatt, Rogers, Shapiro, 
& Erlenmeyer-Kimling, 2002; Buchsbaum et al., 1997; Diforio, Walker, & Kestler, 2000; 
Gooding, Kwapil, & Tallent, 1999; Tallent & Gooding, 1999; Suhr, 1997; Diaz, 
Dickerson, & Kwapil, 2003), while others failed to detect differences (Laurent et al., 
2001; Laurent et al., 2002; Dollfus et al., 2002; Stratta et al., 1997; Byrne et al., 1999).   
Memory.  Considerable evidence indicates that individuals with schizophrenia and 
related disorders (as well as individuals at-risk) have abnormally developed temporal 
lobes and hippocampi (Cannon, 1998; Green, 1998).  These areas of the brain are 
critically involved in memory formation and functioning (Alvarez & Squire, 1994; Squire 
& Alvarez, 1995).  Memory functions include short-term memory, long-term memory, 
working memory, learning, recognition, recall, and interference.  Short term memory is 
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seen as a storage system that temporarily holds information (usually up until 30 seconds) 
(Lezak, 1995).  Tasks that assess this cognitive function include the Digit Span subtest 
from the WAIS-III (Wechsler, 1997), first trial performance on learning tasks, such as the 
California Verbal Learning Test-Second Edition (CVLT- II; Delis, Kramer, Kaplin, & 
Ober, 2000) or Brief Visuospatial Memory Test-Revised (Benedict, 1997), and the 
pairing and free recall components of the Digit Symbol-Coding subtest (Wechsler, 1997).   
Long-term memory is generally measured with tests like the CVLT-II and Brief 
Visuospatial Memory Test-Revised (Benedict, 1997) that involve a delayed recall 
component administered approximately 20 to 30 minutes after hearing a list of words or 
seeing an array of images.  Short-term and long-term memory can also be measured when 
an individual is provided with recall cues or provided with an array or list of stimuli and 
asked to identify the target stimuli (i.e., recognition memory).  Interference, both 
proactive and retroactive, can also be assessed by tests like the CVLT-II.  Proactive 
interference occurs when recently encoded material decreases an individual’s capacity to 
encode new information.  Retroactive interference occurs when newly encoded 
information disrupts an individual’s ability to recall previously stored material.  Studies 
investigating short-term and long-term memory processes in individuals at-risk for 
schizophrenia have yielded both significant (O’Driscoll et al., 2001; Faraone et al., 1999; 
Byrne et al., 1999; Mitropoulou et al., 2002; Egan et al., 2001; Bergman et al., 1998; 
Voglmaier et al., 1997) and non-significant results (Egan et al., 2001; Voglmaier et al., 
2000; LaPorte, Kirkpatrick, & Thaker, 1994).  Interference has not been studied in the at-
risk population. 
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Working memory is an area of neuropsychological functioning that has received 
increasing attention in the study of schizophrenia.  Baddeley (1992) regards working 
memory as a short-term storage system that involves the manipulation of recently stored 
information.  It can be measured by tasks, such as the Letter Number Sequencing subtest 
from the WAIS-III (Wechsler, 1997), which requires participants to encode, rearrange, 
and verbally output a series of letters and numbers.  Investigations of working memory 
performance in individuals at-risk for schizophrenia have produced both significant 
(Cadenhead et al., 1999; Park & McTigue, 1997; Tallent & Gooding, 1999; Myles-
Worsley & Park, 2002) and non-significant (Lenzenweger & Gold, 2000) results.   
Overall, studies of neuropsychological functioning in the at-risk population have 
provided inconsistent results.  One potential explanation for these inconsistencies may be 
that neuropsychological impairment varies according to the specific type of vulnerability 
for schizophrenia.  The Chapman Scales (Perceptual Aberration (Chapman, Chapman, & 
Raulin, 1978), Magical Ideation (Eckblad & Chapman, 1983), Physical Anhedonia 
(Chapman, Chapman, & Raulin, 1976), Revised Social Anhedonia (Eckblad, Chapman, 
Chapman, & Mishlove, 1982)) allow for the examination of neuropsychological 
impairment in relation to differing levels of positive and negative schizotypy.  A 
summary of the investigations examining neuropsychological performance in schizotypy 
samples identified by the Chapman Scales is illustrated in Table 1.  The results listed in 
this table are similar to the findings of investigations using alternative methods to identify 
individuals at-risk for schizophrenia.  Studies, in general, have provided inconsistent 
evidence that neuropsychological impairment is characteristic of vulnerability for 
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schizophrenia.  However, there are a variety of methodological shortcomings that 
characterize these and other studies examining the relationship of schizotypy and 
cognitive functioning that must be addressed before making any definitive conclusions 
regarding the importance of neuropsychological impairment as a means of informing us 
about risk for schizophrenia. 
Critique of the Literature 
Many of the studies in the at-risk literature do not control for crucial variables that 
can impact neuropsychological performance, such as intellectual ability and general 
psychological distress at the time of testing.  Even when studies have controlled for these 
variables, few have explored interactions between them.  For example, it is possible that 
individuals at-risk for schizophrenia with a high IQ may display a different pattern of 
neuropsychological impairment than those at-risk with a low IQ.  Byrne et al. (1999) 
noted such a pattern in their investigation of relatives of patients with schizophrenia.  The 
authors, examining the predicted values for neuropsychological tasks in an ANCOVA 
model using IQ as the covariate found that for two tests, the Rivermead Behavioural 
Memory Test (Wilson, Cockburn, & Baddeley, 1985) and the Hayling Sentence 
Completion Test (Burgess & Shallice, 1996), at-risk participants performed worse than 
controls when IQ was low.  However, when IQ was high (e.g., 110 or above), at-risk 
participants performed better than control participants.  Thus, intellectual ability may 
interact significantly with risk to impact neuropsychological performance.  Simply noting 
that the two groups were equivalent in intellectual ability in this case would have lead to 
the oversight of this potentially important finding. 
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Another shortcoming in the literature involves the consideration of the positive 
and negative symptom dimensions in relation to neuropsychological performance.  
Considering the marked heterogeneity of symptoms in schizophrenia, it is possible that 
different vulnerabilities lead to different symptomatic outcomes.  Therefore, analyzing all 
at-risk participants as a seemingly homogenous group might obscure effects.  For 
example, individuals exhibiting positive symptoms of schizotypy might be characterized 
by a different pattern of neuropsychological dysfunction than individuals exhibiting 
negative symptoms of schizotypy.  It may also be the case that underlying brain 
abnormalities are more prevalent in determining the expression of negative symptoms 
rather than positive symptoms, as some researchers have hypothesized (Tsuang, Stone, & 
Faraone, 2000).  For example, multiple investigations of patients with schizophrenia have 
indicated that neuropsychological impairment is much more strongly related to the 
negative symptom dimension than the positive dimension.  Associations with the positive 
symptom dimension have been weak (Heydebrand et al., 2004; Nieuwenstein et al., 2001; 
O’Leary et al., 2000).  In accordance with the neurodevelopmental model of 
schizophrenia, which emphasizes a continuum of vulnerability and schizophrenia-like 
adjustment, we would expect that the negative symptom dimension of schizotypy should 
be associated with greater neuropsychological impairment than the positive symptom 
dimension.  If this were the case, grouping all schizotypic participants together would 
result in the weakening of power in statistical analyses. 
Another shortcoming in the literature is the use of a limited number of 
neuropsychological tasks.  Investigations that administer a variety of measures typically 
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do not adequately cover the construct(s) of interest (e.g., researchers may tap one area of 
attentional functioning, one area of executive functioning, and a few memory processes), 
or just analyze one domain of functioning (e.g., memory) and compare groups on 
individual test variables.  Administering a larger variety of tests would increase the 
chance that constructs are sufficiently covered and would also enhance detection of true 
differences if they were present. 
Although it seems appropriate to choose a wide range of neuropsychological tests 
to assess impairment in the at-risk population, there has been considerable debate 
regarding how to analyze the abundance of data produced by such a battery.  Many 
researchers have chosen to perform t-tests or regression analyses on individual 
neuropsychological indices.  However, this approach increases the probability of the 
Type I error and the individual neurocognitive measures may not adequately represent the 
underlying constructs the battery of tests are thought to be collectively measuring.  
Another approach is to create overall construct scores by averaging performance on all 
indices from a particular domain, such as attention.  Similar to the analysis of individual 
variables, this method also has its faults, including reliance on hypothetical formulations 
of which tests are measuring which abilities, the yielding of less complete information 
regarding the construct of study, and indices with questionable reliability.  For example, 
researchers have proposed various models of neuropsychological functioning and some 
tests have been conceptualized as emphasizing more than one domain (e.g., the Stroop 
Test has been viewed as a test of attention as well as executive functioning).  Moreover, 
although an individual test may measure one ability more so than another (e.g., Digit 
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Span may tap memory processes more than attentional processes), tests may contribute 
valuable information to more than one domain of interest.  Thus, averaging test scores to 
represent a single construct precludes consideration of the influences a variable may have 
on multiple neuropsychological functions.   
One way to address these limitations is to perform a principal components 
analysis, which minimizes the chance for the Type I error, while providing valuable 
information regarding the underlying constructs the tests are measuring.  This method 
also allows single variables to contribute weighted information to multiple constructs of 
interest.  Liu, Zhang, Gehan, and Clarke (2002) have suggested using block principal 
component analysis when analyzing data sets with a very large number of variables, such 
as gene microarray studies that can include over 500 variables.  Block principal 
component analysis involves forming subgroups of conceptually related variables and 
performing multiple parallel factor analyses.  Afterwards, the variables that explain the 
most variance from each analysis are selected and combined for a final factor analysis. 
Hypotheses and Goals of the Current Study 
The goals of the present study are to examine the relationships between 
psychometrically assessed schizotypy and neuropsychological performance in a sample 
of nonpsychotic college students.  Schizophrenia is characterized by a variety of 
neuropsychological deficits.  Neurodevelopmental accounts of schizophrenia postulate 
that certain etiologically relevant biological abnormalities present in schizophrenia are 
likely represented to a milder degree prior to the onset of psychosis.  Consistent with this 
account, neuropsychological impairment should be evident in those at-risk for 
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schizophrenia if it is not merely a secondary consequence of having the disorder.  Given 
that risk and eventual symptom presentation are conceptualized as being expressed across 
a dynamic continuum, impairment should also vary according to level of risk and severity 
of illness (i.e., those at high risk for schizophrenia, or with chronic schizophrenia, should 
display greater neuropsychological impairment than those who are at low risk or exhibit a 
milder course of the disorder).  The current study separately assessed the relationship of 
positive schizotypy, negative schizotypy, and their interaction, with multiple domains of 
neuropsychological functioning.  It is hypothesized that elevations in schizotypy will be 
associated with neuropsychological impairment above and beyond the effects of 
intellectual ability and general psychological distress.  Given that neuropsychological 
impairment has been more closely tied to the negative symptoms of schizophrenia, it is 
further hypothesized that the negative symptom dimension of schizotypy will be more 
strongly associated with neuropsychological impairment than the positive symptom 
dimension of schizotypy.  Lastly, in order to evaluate the possibility that intellectual 
ability might differentially impact neuropsychological functioning for those at-risk for 
schizophrenia, the interaction between the schizotypy dimensions and estimated IQ will 
be examined.  Note that college students appear to provide an appropriate sample for 
examining the relationship between schizotypy and cognitive functioning.  Although 
college graduates exhibit a slightly lower lifetime prevalence of schizophrenia than the 
general population (Robins et al., 1984), longitudinal studies have reported that 
psychometrically identified schizotypic college students are at heightened risk for 
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developing psychotic disorders and schizophrenia-spectrum illnesses (e.g., Chapman et 
al., 1994; Kwapil, 1998). 
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CHAPTER II 
METHOD 
Participants  
 Participants were identified by scores on the Perceptual Aberration, Magical 
Ideation, Physical Anhedonia, and Revised Social Anhedonia Scales.  These scales were 
administered to approximately 1800 undergraduate students enrolled in general 
psychology courses at the University of North Carolina at Greensboro over the course of 
four semesters.  Putatively schizotypic participants who received standard scores of at 
least + 1.96 on any of these scales, and a subset of control participants who received 
standard scores of less than + 0.5 on each scale, were invited to participate in the 
neuropsychological assessment.  This selection process ensured variation at both ends of 
the schizotypy dimension (i.e., the study was guaranteed to contain the low and high 
scorers necessary for evaluating the effect of schizotypy on neuropsychological 
impairment).  In addition, high scorers on one of the schizotypy scales typically had a 
range of scores on the other scales, which ensured variation across the entire distribution.  
The items from the schizotypy scales were intermixed with a 13-item infrequency scale 
(Chapman & Chapman, 1983) that was designed to screen out participants who 
responded in a random or “fake-bad” manner.  Participants who endorsed three or more 
items on the infrequency scale were omitted from participation in the study.  Over the 
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four semesters, a total of 156 participants completed the neuropsychological assessment 
(67 controls, 89 at-risk).  With regard to race and gender, the sample consisted of 119 
Caucasian and 37 African-American participants, and 125 females and 31 males.  
Participants had a mean age of 19.1 years (SD = 3.2 years, range = 17-43 years of age).   
Materials   
 
 Schizotypy inventories.  The Revised Social Anhedonia Scale consists of 40 items 
that tap asociality and indifference to others.  Sample items include, “Having close 
friends is not as important as people say” [keyed true] and “I sometimes become deeply 
attached to people I spend a lot of time with” [keyed false].  The Perceptual Aberration 
Scale consists of 35 items that tap schizotypal perceptual experiences and bodily 
distortions.  Sample items include, “I sometimes have the feeling that some parts of my 
body are not attached to the rest of me” [keyed true] and “My hands and feet have never 
seemed far away” [keyed false].  The Magical Ideation Scale is made up of 30 items that 
measure belief in implausible or invalid causality.  Sample items include, “I have 
occasionally had the silly feeling that a TV or radio broadcaster knew I was listening to 
him” [keyed true] and “Numbers like 13 and 7 have no special powers” [keyed false].  
The Physical Anhedonia Scale includes 61 items that measure deficits in sensory and 
aesthetic pleasure.  Sample items include, “There are not many things that I ever really 
enjoyed doing” [keyed true] and “Beautiful scenery has been a great delight to me” 
[keyed false].   
 The schizotypy scales were constructed using Jackson’s (1970) method for 
rational scale development.  All items were carefully selected to ensure high item-scale 
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correlations while ruling out correlations with acquiescence and social desirability.  The 
coefficient alpha internal consistency reliabilities of each scale were in the .80’s in the 
present sample and they are reported to have test-retest reliability of .75 to .84 over a six 
week interval (Chapman, Chapman, & Miller, 1982).  The Chapman scales have been 
widely used in cross-sectional and longitudinal studies of schizotypy.  Groups identified 
as at-risk by the schizotypy scales tend to show psychological and physiological deficits 
similar to those seen in patients with schizophrenia (e.g., Edell, 1995; Fernandes & 
Miller, 1995) and to be at an elevated risk for developing schizophrenia-spectrum 
disorders (Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994; Kwapil, 1998).   
 Principal components analysis of the four Chapman Scales with approximately 
6000 college students assessed in our laboratory produces a two-factor solution that 
accounts for approximately 80% of the variance in the scales.  An oblique (Promax) 
rotation results in a Positive Schizotypy factor (with loadings of .91 from both the 
Perceptual Aberration and Magical Ideation Scales and .39 from the Revised Social 
Anhedonia Scale) and a Negative Schizotypy factor (with loadings of .85 from the 
Physical Anhedonia and .79 from the Revised Social Anhedonia Scales).  The two factors 
are minimally correlated (r = .10).  Each participant in the present study was assigned a 
dimensional score on the Positive and Negative Schizotypy factors based upon the 
original analysis of the unselected sample. 
Head injury and drug abuse.  In order to rule out the impact of head injury on 
neuropsychological performance participants were asked if they have ever experienced a 
concussion (“Have you ever lost consciousness after a blow to the head or been 
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diagnosed with a concussion?  If so, how many times?”).  According to guidelines used 
in similar studies (e.g., Kremen, Seidman, Faraone, Toomey, & Tsuang, 2004), 
participants were excluded from the study if they reported loss of consciousness for more 
than 5 minutes or suffered a head injury that was accompanied by documented 
neuropsychological impairment.  Participants were also precluded from participation if 
they endorsed current substance abuse.  No participants met the exclusion criteria, 
although one participant was excluded from the study because he admitted to substance 
use on the day of testing.  This participant was not contacted to return at a later date to 
complete the experiment. 
Intelligence.  The Vocabulary and Block Design subtests from the WAIS-III were 
used as an estimate of Full Scale IQ based upon the recommendations of Brooker and 
Cyr (1986). 
General Psychological Distress.  The Brief Symptom Inventory (Derogatis, 
1993), a 53-item self-report scale, is a measure of general psychological distress and 
includes 9 dimensional symptom scales and 3 global indices.  Items are rated on a 5-point 
scale and the measure takes about 5-10 minutes to complete.  The Global Severity Index 
reflects the average rating per item and serves as a measure of general psychological 
distress.  T-scores were computed using norms for adult nonpatient males and females 
(Derogatis, 1993). 
Continuous Performance Test-Identical Pairs.  The CPT-IP measures sustained 
attention by requiring the participant to focus on a computer screen that presents various 
four-digit numbers (in one condition) and shapes (in a separate condition) for a short 
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duration.  Both of these conditions are also presented on separate trials with distraction, 
making for a total of four conditions.  The participant is instructed to release the 
computer mouse button whenever two identical stimuli appear on consecutive trials.  A 
signal detection index, d’, is the most commonly studied variable of the CPT-IP and is 
considered to be a relatively pure measure of sustained attention since it controls for 
response bias.  Each participant’s d’ score was averaged across the four conditions (α = 
.78) to establish an overall d’ score for that individual.  
The Stroop Color and Word Test.  The Stroop Color and Word Test requires 
participants to focus on a single stimulus aspect and provide a verbal response, while 
ignoring other stimulus characteristics.  During the first part of the task, the color trial, 
the participant is instructed to name the color of a series of stimuli (i.e., XXXX) printed 
in different colors of ink.  In the second part of the task, the word component, the 
participant sees a list of color names but must verbalize the color of the ink the word is 
printed in rather than the actual word (color name).  This component of the task is much 
more difficult since people have an automatic tendency to read words when they enter 
their visual field.  Some researchers have considered this component of the Stroop test to 
be a measure of executive functioning given the emphasis on response inhibition.  Four 
indices of this test were used in analyses, including the total number of correctly 
completed items for the color and word conditions, and the time needed to complete the 
stimulus set for the color and word conditions.   
The Trail Making Test.  Part A of this task involves connecting lines between 
circumscribed, randomly distributed numbers presented on a sheet of paper, in a 
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consecutive fashion from 1 to 24.  Part B involves connecting numbers to letters in an 
alternative fashion.  Completion times for each part of the test were used as the dependent 
variables for this test. 
Digit Symbol-Coding.  This test is part of the WAIS-III and involves quickly 
filling in empty boxes with symbols within a two-minute time frame.  Each empty box is 
below a number and each number has its own unique symbol which the examinee can 
reference at the key at the top of the test form.  The age-normed standard score was used 
as the dependent variable for this task. 
Arithmetic and Digit Span.  These two measures are also from the WAIS-III.  The 
Digit Span task requires the participant to verbally recall a string of digits orally 
presented at the rate of one digit per second.  The Arithmetic subtest presents the 
participant with a series of math problems that must be solved without the use of a pencil 
and paper.  The age-normed standard scores from each of these tasks were used as 
dependent variables from these tasks. 
 Wisconsin Card Sorting Test.  During this computerized task, participants must 
sort 128 cards with various figures on them based on three unspecified sorting rules 
(color, number, and shape).  It is considered to tap the conceptual functions component of 
executive functioning, but has also been described as a measure of attention (Mirsky et 
al., 1991).  The primary dependent variables that were analyzed from this task were the 
number of categories achieved, percent conceptual level response, percent perseverative 
errors, and percent non-perseverative errors.  The degree to which a participant 
perseverates has been a widely studied variable in individuals at-risk for schizophrenia 
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and is thought to measure sensitivity to contingent feedback (Wagman & Wagman, 
1992).  Categories completed and percent conceptual level response measure an 
individual’s ability to shift mental sets and discover underlying guiding principles to 
completing the task. 
Controlled Oral Word Association Test.  This task requires participants to say as 
many words as possible that begin with a particular letter within a one-minute time 
frame.  The version of this task used in this investigation included three trials, one for 
each of the letters C, F, and L.  The dependent variable examined from this task was the 
total number of words produced across the three trials.  Verbal fluency tasks have been 
associated with left frontal lobe damage (Milner, 1975).  Some researchers have viewed 
this task as a measure of memory since the individual must retrieve information from 
long-term memory in order to perform well (Gabrielli et al., 1998; Raichle et al., 1994). 
Mazes.  The Mazes task from the WISC-III is thought to assess planning ability 
(Lezak, 1995).  This task involves presenting the participant with a printed maze and 
asking them to find their way out by drawing a path with a pencil from the starting point 
to the ending point within a short period of time.  Errors are noted when the individual 
enters a blind alley (i.e., a pathway that is closed off) or draws through a wall.  Since all 
participants completed all of the mazes, the total number of errors was used as the 
dependent variable for this task. 
 Ruff Figural Fluency Test.  This test requires the participant to draw as many 
unique designs as possible by connecting pre-arranged dots with straight lines within a 
one-minute time period.  This test contains five different stimulus sheets, but for this 
   
24 
study only parts 3 and 5 were used in order to shorten the administration time.  The sum 
of designs across trials 3 and 5 and the error ratio, which reflects the percentage of 
duplicate designs, were used as the dependent variables for this task.  
 California Verbal Learning Test-Second Edition.  The CVLT-II was used as a 
measure of short-term memory, long-term memory (recognition, free recall, cued recall), 
learning strategies, and interference (retroactive and proactive).  During this task, 
participants are orally presented a list of 16 words (List A) and asked to repeat as many 
words as they can remember.  List A contains four categories of words (furniture, 
vegetables, ways of traveling, animals) each represented by four words.  The list is 
presented for 5 trials after which the participant is presented with a distractor word list 
that they must immediately recall (List B).  Participants are then given a free recall trial 
of List A, cued recall trials, and then a break of 20 minutes.  After the break, long-term 
free and cued recall are assessed.  Two learning strategy variables, semantic and serial 
clustering, provide insight into the participant’s encoding strategies.  High semantic 
clustering scores indicate that a participant tended to group words together according to 
category when recalling the list (a more efficient encoding strategy), whereas high serial 
clustering indicates that the participant tended to recall words in a rote fashion (generally 
a less efficient strategy).   
 Brief Visuospatial Memory Test-Revised.  This task involves the 10 second 
presentation of a 2 x 3 array of geometric figures on an 8 ½ x 11 inch stimulus card for 
three learning trials.  After each trial, the card is taken away, and the participant is asked 
to draw as many figures as they can recall on a separate page.  After a 25-minute delay, 
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the participant is asked to once again draw the figures.  First trial performance and 
percent recall of the delay trial were used as dependent variables for this task.   
Letter-Number Sequencing.  This task from the WAIS-III was designed to 
measure verbal working memory.  During this task, participants hear a string of letters 
and numbers and are then asked to first recall the numbers in order (from smallest to 
largest) and then the letters (in alphabetical order).  The Letter-Number Sequencing task 
has seven levels, each containing three trials.  The first level includes a two-item string, 
and each consecutive level has a string increased by one, making the most challenging 
level an eight-item string.  Testing is discontinued when an individual fails all three trials 
within a level.  The age-normed standard score was used as the dependent variable for 
this task. 
Selection of Variables for Analysis.  The current investigation incorporated a 
variety of neuropsychological variables that were chosen based upon their established 
psychometric properties, frequency of use in the schizophrenia literature, ability to 
convey unique information, and their coverage of the three major multidimensional 
neuropsychological constructs (attention, memory, and executive functioning).  For 
example, the total number of errors was chosen as the most relevant variable for the 
Mazes subtest because the overall item score does not convey as much information (e.g., 
once a person makes a certain number of errors, they are given a zero score for a 
particular item, which can limit information about the number of errors for that item).  
Moreover, the overall score for the Mazes subtest was excluded because it conveys nearly 
the same information as the error score.  Similarly, it was thought most efficient and 
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meaningful to choose one variable (the three trial sum) on the verbal fluency task rather 
than four variables that include redundant information, such as each trial score and the 
overall score.  This line of reasoning was applied to each measure until a final set of 29 
variables was achieved.  Table 2 displays the final measures selected and the relevant 
variables from each test that were used in analyses.  
Procedure 
 Schizotypy questionnaires.  The schizotypy questionnaires were administered at 
the beginning of the Fall 2003, Spring 2004, Fall 2004, and Spring 2005 semesters to 
students enrolled in general psychology courses at UNCG.  Candidate at-risk and control 
participants were contacted by telephone and invited to participate in the 
neuropsychological assessment.  Participants who had corrected vision or audition, were 
not allowed to participate if they did not wear corrective lenses or devices on the day of 
testing. 
Neuropsychological assessment, IQ, and questionnaires procedure.  The entire 
assessment lasted approximately two and a half hours.  Participants were informed that 
they could withdraw from the project at any point if they felt uncomfortable or distressed, 
although no participants requested to do this during the study.  All of the measures were 
administered by the principal investigator (an advanced graduate student) and four 
undergraduate assistants who were extensively trained in the administration of these 
measures and received ongoing weekly supervision throughout the course of the study.  
All materials were scored by the principal investigator.  Data entry was completed by the 
principal investigator and verified by an undergraduate assistant.  Participants, the 
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principal investigator, and the experimenters were unaware of each participant’s 
performance on the schizotypy scales. 
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     CHAPTER III 
RESULTS 
Reduction of Neuropsychological Data   
Table 3 provides correlation matrices of the variables typically viewed as 
belonging to the attention, executive functioning, and memory constructs of 
neuropsychological functioning, as they relate to all of the selected variables.  As can be 
seen, there were generally modest intra-correlations among the neurocognitive measures 
presumed to assess the three a priori defined areas of cognition.  Therefore, a principal 
components analysis with oblique rotation was conducted on all of the 
neuropsychological measures.  Given that the number of variables in the investigation 
was not particularly large, and yielded a participant-to-variable ratio of 5.4, principal 
components analysis, rather than block principal component analysis, was the appropriate 
method of data reduction for the neuropsychological data.  This method was selected in 
order to minimize the chance of the Type I error, allow for individual variables to 
contribute weighted information to multiple constructs, and to provide robust underlying 
neuropsychological factors that could be used to determine the relationship between 
neuropsychological impairment and schizotypy.  A similar approach has been endorsed 
recently in the MATRICS project, a nationwide research effort investigating 
neuropsychological impairment in patients with schizophrenia (Nuechterlein et al., 2004). 
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As illustrated in Table 4, the analysis yielded five factors that accounted for 47% of the 
variance in neuropsychological performance.  The five factors were labeled as follows: 1) 
Executive Functioning; 2) Processing Speed; 3) Sustained Attention; 4) Long-term 
Memory; and 5) Interference.  Based upon the factor analysis for the neuropsychological 
measures, each participant was assigned a dimensional score for each factor.  Table 5 
displays the correlations between the neuropsychological factor scores.      
Schizotypy and Cognitive Functioning 
Hierarchical regressions were computed using each of the five 
neuropsychological factor scores as dependent variables with the following order of 
predictor variables.  In order to determine the impact of schizotypy on 
neuropsychological performance above and beyond the influence of current 
psychological distress and intellectual ability, the Brief Symptom Inventory-Global 
Severity Index was entered at Step 1, followed by Estimated IQ at Step 2.  In order to 
examine the differential impact schizotypy type might have on neuropsychological 
performance, Negative Schizotypy was entered at Step 3 followed by Positive Schizotypy 
at Step 4.  Negative schizotypy was entered before positive schizotypy because of the 
stronger relationship that exists between negative symptoms and neuropsychological 
functioning in studies of patients with schizophrenia.  The interaction term between 
Positive and Negative Schizotypy was entered at Step 5.  Lastly, in order to evaluate the 
hypothesis that differing levels of intellectual functioning and level and/or type of 
schizotypy may interact with each other to impact neuropsychological performance, steps 
6, 7, and 8 were added that consisted of interaction terms between these constructs 
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(Negative Schizotypy x IQ, Positive Schizotypy x IQ, Positive x Negative x IQ).  It 
should be noted that while the Positive and Negative Schizotypy factor scores were 
derived using principal components analysis with an oblique rotation, the two schizotypy 
factors were not significantly associated with IQ (r = .02 and .05 respectively).  
Likewise, IQ was not associated with current symptoms as measured by the Brief 
Symptom Inventory-Global Severity Index (r = -.03).  However, current symptoms were 
correlated significantly with Positive Schizotypy (r = .57, p < .001) and Negative 
Schizotypy (r = .32, p < .001). 
As Table 6 illustrates, intellectual functioning explained a significant proportion 
of the variance in the Processing Speed, F(1,138) = 5.71, p < .05, Sustained Attention, 
F(1,138) = 30.64, p < .001, and Long Term Memory, F(1,138) =  11.33, p < .001, factor 
scores.  In each case, neuropsychological impairment was associated with lower IQ 
scores.  General psychological distress did not explain a significant amount of the 
variance in neuropsychological performance.  However, a trend was evident for 
Sustained Attention, F(1,139) = 3.56, p < .10, although, paradoxically, the endorsement 
of symptoms was associated with improved performance.  With regard to schizotypic 
symptom type, Positive Schizotypy accounted for a significant amount of variance for the 
Executive Functioning, F(1,136) = 4.26, p < .05, Sustained Attention, F(1,136) = 6.41, p 
< .01, and Interference factors, F(1,136) = 3.69, p < .05, above and beyond the 
independent effects of intellectual functioning, general psychological distress, and 
negative schizotypy.  In each case, neuropsychological impairment was associated with 
elevated Positive Symptom schizotypy scores (i.e., greater endorsement of schizotypy 
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was associated with more neurocognitive impairment).  In contrast, Negative Schizotypy, 
as well as the interaction between Negative and Positive Schizotypy, did not account for 
a significant proportion of variance for any of the neuropsychological factors.  One 
interaction term, a three-way interaction between Positive Schizotypy, Negative 
Schizotypy, and IQ, was evident for the Processing Speed factor F(1,132) = 4.79, p < .05.  
Specifically, high scores on both of the schizotypy, combined with low IQ, was 
associated with poorer Processing Speed.  None of the other interaction terms involving 
schizotypy and IQ were significant.  Note, that recomputations of the regression analyses 
separately for males and females did not produce any substantive differences in the 
results.   
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CHAPTER IV 
DISCUSSION 
 
 The current study investigated neuropsychological functioning in relation to the 
degree of schizotypy.  A principal components analysis yielded five underlying 
neuropsychological factors of Executive Functioning, Processing Speed, Sustained 
Attention, Long Term Memory, and Interference.  Although the factor structure of the 
measures used in this investigation did not map onto the a priori view of attention, 
executive functioning, and memory, it was consistent with other current findings in the 
literature that have employed factor analysis (Nuechterling et al., 2004).  It should also be 
noted that the focus of the current study was not to describe the underlying factor 
structure of cognitive abilities, but rather to examine the relationship between symptom 
dimensions of schizotypy and neuropsychological performance.  Furthermore, the nature 
of the sample and selection procedures precludes making broader interpretations about 
the structure of neuropsychological functioning in young adults. 
For three of the neuropsychological factors, Processing Speed, Sustained 
Attention, and Long Term Memory, intellectual ability explained a significant amount of 
the variance in neuropsychological performance, highlighting the need for researchers to 
control for this variable when investigating neuropsychological functioning.  Consistent 
with the main hypothesis, neuropsychological impairment was associated with 
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schizotypy.  High scores on the Positive Schizotypy factor were associated with deficits 
in neuropsychological functioning for three of the five factors (Executive Functioning, 
Sustained Attention, Interference).  Moreover, general psychological distress did not 
account for significant variation in neuropsychological performance.  It should be noted, 
however, that the Brief Symptom Inventory, which was used as a measure of general 
psychological distress, does not include items related to Attention Deficit/Hyperactivity 
Disorder, which potentially may have impacted the current findings.  In contrast, 
Negative Schizotypy factor scores were not associated with neuropsychological 
impairment despite fairly consistent evidence to the contrary in samples of patients with 
schizophrenia (Heydebrand et al., 2004; Nieuwenstein et al., 2001; O’Leary et al., 2000).  
Lastly, one interaction term was related to neuropsychological performance.  
Specifically, impaired processing speed was associated with a combination of high factor 
scores on Positive and Negative Schizotypy and low scores on estimated IQ.  In this 
regard, higher IQ scores may have served as a protective factor against 
neuropsychological impairment for those participants with high positive and negative 
schizotypy features.  This finding is similar to a performance pattern noted in Bryne et al. 
(1999).   
Taken together, these findings warrant several considerations.  First, the 
inconsistencies noted in the at-risk literature may be partially explained by the grouping 
of schizotypes with differing levels and types of impairment.  If positive schizotypes are 
more neuropsychologically impaired than negative schizotypes, grouping all of these 
individuals together when making statistical comparisons may weaken the power of the 
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statistical analyses.  In addition, given the evidence in this study that intelligence can 
explain a significant proportion of the variance in neuropsychological performance, 
failure to account for this variable could lead to misleading statistical results.     
The absence of a significant relationship between neuropsychological dysfunction 
and Negative Schizotypy is contradictory to the hypothesis that this dimension is 
associated with neuropsychological impairment across the continuum of vulnerability for 
schizophrenia.  There are several possible explanations for this finding.  The most 
reasonable explanation seems to be that the heterogeneity that characterizes 
neuropsychological functioning in the schizophrenic population is mirrored by 
heterogeneity of less deviant deficits in the at-risk population.  For example, the literature 
concerning neuropsychological impairment in the at-risk population has been 
inconsistent.  Likewise, the relationship between Positive Schizotypy and 
neuropsychological performance in the current study was modest, suggesting that 
neuropsychological impairment does not seem to be a prominent trait of individuals at-
risk for schizophrenia.  Thus, it seems that the phenotypic neuropsychological 
heterogeneity that has been noted in the schizophrenic population appears to be present in 
the at-risk population as well.  However, the importance of neuropsychological 
impairment should not be discounted.  It is possible that a subgroup of individuals with 
high schizotypy scores and neuropsychological impairment are at especially heightened 
risk for developing schizophrenia.  Perhaps, in this particular sample, there were not as 
many individuals with neuropsychological impairment and high Negative Schizotypy 
scores to account for a significant amount of variance in neuropsychological 
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performance.  The present sample was predominantly female and although not 
extensively studied, the literature suggests that males may be more prone to negative 
symptoms and neuropsychological deficits (Leung & Chue, 2004).  Perhaps a more 
substantial representation of male schizotypes would have strengthened the relationship 
between negative symptoms and cognitive dysfunction.  An analysis of individual 
profiles might help to identify a group of individuals at-risk who have an etiologically 
specific vulnerability for schizophrenia.  Identifying such individuals and tracking their 
development in a longitudinal investigation would help address these issues. 
An alternative hypothesis is that the vulnerability for negative symptom 
schizophrenia may not significantly impact neurocognition prior to the onset of the first 
episode.  The findings of this study highlight the possibility that there are crucial 
developmental changes that occur as one moves along the continuum from vulnerable to 
symptomatic.  As the presumed anatomical and functional changes that produce negative 
symptoms become more prominent, they may have a qualitatively different impact on an 
individual’s ability to process information in comparison to the substrates of positive 
symptoms.  Such a conjecture would be consistent with the social drift hypothesis that 
individuals experience debilitating effects after the onset of their first episode of 
schizophrenia that cause them to drift downward on the socioeconomic ladder.  In 
contrast, the disrupted neural networks responsible for the development of positive 
symptoms may impair neuropsychological functioning in a more consistent and mild 
manner throughout the course of the illness.  While these ideas are indeed speculative, 
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there is a distinction in this sample between schizotypy symptom type and 
neuropsychological ability.   
Another potential explanation for the lack of an association between negative 
symptoms and neuropsychological impairment is that schizotypic individuals with 
primarily attenuated negative features are able to utilize alternative areas of the brain to 
enhance their performance.  This hypothesis can be examined by studying the metabolic 
activity in different areas of the brain while engaging in neuropsychological tasks.  A 
study by Volz et al. (1999) found differential brain activation patterns in individuals with 
schizophrenia and control participants while performing the Continuous Performance 
Test.  Specifically, the authors found that when patients were matched with controls for 
performance, patients with low Continuous Performance Test scores displayed greater 
activation in the right temporal lobe and less activation in the left dorsolateral prefrontal 
cortex in comparison to poor performing control participants.  Such findings highlight 
that latent neuroanatomical and neurophysiological abnormalities may be evident in those 
at-risk for schizophrenia even though their manifest neuropsychological performance is 
indistinguishable from controls.  As neuroimaging techniques become more advanced 
and cost-effective, this paradigm of analysis will likely elucidate the relationship between 
risk for schizophrenia and neuropsychological impairment, as well as the veracity of 
claims that such impairment is indicative of vulnerability for the disorder.  This 
methodological approach to studying neuropsychological functioning should also help 
clarify the relationship between cognitive impairment and pre- and post-morbid symptom 
variation. 
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Another advancement in the future study of neuropsychological impairment in the 
development of schizophrenia will be the inclusion of more comprehensive test batteries.  
As noted earlier, the most effective way to test neuropsychological functioning is to 
ensure adequate coverage of the constructs which serve as the basis for conclusions.  
Recent cooperative efforts by researchers from academic, government, and patient 
advocate groups have reached a similar consensus since forming the NIMH- 
Measurement and Treatment Research to Improve Cognition in Schizophrenia 
(MATRICS) Initiative.  One of the major goals of this initiative is to scientifically 
demonstrate the importance that cognitive impairment has on everyday functioning for 
patients with schizophrenia (Nuechterlein et al., 2004).  The battery chosen for the 
current study was chosen prior to the formation of this committee.  However, as Table 7 
demonstrates, the MATRICS battery is very similar to the one employed in this 
investigation.  One notable absence from the MATRICS battery is the WCST, which was 
not included because the authors only selected tests suitable for longitudinal assessments.   
The battery chosen by the MATRICS Neurocognition Committee was constructed 
after carefully examining all factor analytic studies conducted with patients with 
schizophrenia.  This review of the literature provided the authors with confidence that 
there are meaningful and separable cognitive factors in schizophrenia.  These factors are 
included in Table 7 as “Cognitive Domains” and are similar to the factors extracted in the 
current investigation (Nuechterlein et al., 2004).  The authors noted that the inclusion of 
the Social Cognition factor, which was not evident in factor analyses, was based upon 
new research suggesting that social cognition may serve as a mediator between 
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neuropsychological impairment and functional outcome in schizophrenia (Brekke et al., 
2003).  The consistency between these two independent efforts approximates a cross-
validation of these underlying neuropsychological functions and encourages the use of 
similar comprehensive batteries in future examinations of neuropsychological functioning 
in schizophrenia and those at-risk for the disorder.
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APPENDIX A   
 
TABLES 
 
Table 1 
Summary of Neuropsychological Findings in Samples Using Chapman Scales 
 
       Neuropsychology  
Study   Sample   Measures   Findings 
 
Lenzenweger  31 schizotypic  CPT-IP    d’: NS 
(2001)      26 controls     ln β: NS 
   Per-Ab      Hits: NS 
         False Alarms: NS 
         Reaction Time: C < S 
    
Obiols   35 Per-Ab  CPT-IP   d’: Per-Ab < C 
(1993)   33 controls 
 
Laurent et al.  23 schizophrenia  CPT-IP   Fast Numbers (3FN): 
(1999)   45 first-degree relatives    d’: NS 
   36 controls     ln β: NS 
   Soc & PhyAnh     ln random: NS 
 
         Fast Numbers (4FN): 
         d’: NS 
         ln β: NS 
         ln random: Sc < R, C 
 
         Slow Numbers: 
         d’: NS 
         ln β: NS 
         ln random: Sc < R, C 
          
         Fast Shapes: 
         d’: Sc, R < C 
         ln β: NS 
         ln random: NS 
          
         Slow Shapes: 
         d’: NS 
         ln β: NS 
         ln random: NS 
         
Soc & Phy Anh not 
related to d’  
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Table 1 (continued) 
 
 
Neuropsychology  
Study   Sample   Measures   Findings 
 
Franke et al.  35 schizophrenia  CPT-IP   d’: Sc, R < C 
(1994)   26 healthy siblings     ln β: Sc < C  
   35 controls  
   Per-Ab, PhyAnh     Per-Ab, Phy Anh not  
         related to CPT-IP  
         variables 
 
 
Gooding et al.  97 Per-Mag  WCST   Categories Completed: 
(1999)   58 SocAnh     Per-Mag, SocAnh < C 
104 controls     Perseverative Errors: 
         Per-Mag, SocAnh > C 
Non-Perseverative Errors: 
 NS 
Trials to 1st: NS 
         Conceptual Level  
         Response: NS 
         Failure to Maintain Set: 
         Per-Mag, SocAnh > C 
 
Tallent & Gooding  49 SocAnh  WCST   Categories Completed: 
(1999)   66 Per-Mag  Working Memory task SocAnh < Per-Mag, C 
63 controls     Perseverative Errors: NS 
Non-Perseverative Errors:  
 NS 
Trials to 1st: NS 
         Conceptual Level  
         Response: NS 
         Failure to Maintain Set: 
         Per-Mag, SocAnh > C 
          
         Working Memory:  
         % Correct: SocAnh, Per- 
         Mag < C 
         Reaction Time: SocAnh >  
         C 
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Table 1 (continued) 
 
 
Neuropsychology  
Study   Sample   Measures   Findings 
 
Suhr (1997)  56 Per-Mag  WCST   Perseverative Errors:  
   42 controls  Stroop Color & Word Per-Mag > C 
Trail Making Test % Perseverative Errors:  
Tower of Hanoi  Per-Mag > C 
COWAT  Categories Completed: NS 
         Failure to Maintain Set:  
         NS 
    
   Stroop Color & Word:  
         Interference: Per-Mag > C 
 
         Trail Making Test- Part B: 
         Time to Completion: NS 
 
         Tower of Hanoi: 
         Number of Moves: NS 
        
         COWAT: 
         Total Fluency Score: NS 
      
 
LaPorte et al.  409 participants  Wechsler Memory Logical Memory: 
(1994)   Per-Mag, SocAnh Scale- Revised  Immediate Recall: NS 
   Scales      Delayed Recall: NS 
         % Retained: NS 
 
Lenzeweger &  31 Per-Ab  Verbal Memory Task Verbal Memory Test: 
Gold (2000)  26 controls  Letter Number Span Immediate Recall: NS 
    Delayed Recall: NS 
 
    Letter Number Span: 
    Total Correct: NS 
    Longest String: NS 
 
 
Gooding et al.  63 Per-Mag  WCST   Categories Completed: 
 (2001)   62 SocAnh     Per-Mag, SocAnh < C 
83 controls      Non-Perseverative Errors:  
       NS 
      Trials to 1st: NS 
         Conceptual Level  
         Response: NS 
         Failure to Maintain Set:  
         NS 
         Perseverative Errors: NS 
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Table 1 (continued) 
 
Neuropsychology  
Study   Sample   Measures   Findings 
 
Franke et al.  57 Schizophrenia  WCST   Perseverative Errors: 
(1993)    32 healthy siblings Verbal Fluency Test Sc, R > C 
   32 controls  Trail Making Test Non-Perseverative Errors: 
   PhyAnh Scale     Sc  > C 
         Conceptual Level  
         Response: Sc, R < C 
         Categories Completed: 
         Sc, R < C 
 
         Trail Making Test: 
         Time to Completion A &  
         B:  Sc, R > C 
 
Verbal Fluency Test: 
Number of Words 
Produced: 
Sc, R < C 
 
PhyAnh associated with 
impairment on WCST, 
TMT, & Verbal Fluency 
Test 
 
Barrantes-Vidal   270 normal  Digit Span  Digit Span: NS 
et al. (2003)  adolescents  Digit Symbol   Digit Symbol: Mixed < 
Positive, C 
   Per-Ab, SocAnh  COWAT  CPT-IP: NS 
   PhyAnh  (Positive, CPT-IP   COWAT: Mixed <  
   Negative, Mixed,     Positive, C 
   Control)   WCST   WCST- Failure to  
         maintain set: 
      Trail Making Test A Negative > Positive,  
         Mixed 
         Trail Making Test A: NS 
 
Rosa et al. (2000)  260 young adolescents WCST (Factor 1)  Factor 1: NS 
Per-Ab, PhyAnh, SocAnh Trail Making Test Factor 2: Negative  
       Schizotypy  
 Factor Analysis   Controlled Oral Word related to impairment       
 yielded Positive  Association Test    
   and Negative  Raven Progressive  
   Schizotypy Scores Matrices (Factor 2)  
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Table 1 (continued) 
 
 
Per-Ab = Perceptual Aberration Scale 
Per-Mag = Combination of Perceptual Aberration and Magical Ideation Scales 
PhyAnh = Physical Anhedonia Scale 
SocAnh = Social Anhedonia Scale 
 
Sc = Patients with schizophrenia 
R = Relatives of patients with schizophrenia 
S = Schizotypy participants 
C = Control participants 
NS = Not significant 
 
CPT-IP = Continuous Performance Test- Identical Pairs 
WCST = Wisconsin Card Sorting Test 
COWAT = Controlled Oral Word Association Test 
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Table 2 
Selected Measures of Attention, Executive Functioning, and Memory 
Attention 
 Trail Making Test 
 Part A- Completion time 
 Part B- Completion time 
 
 Digit Symbol- Coding subtest (WAIS-III)  
Standard score 
 
 Stroop Color and Word Test  
Color- Number correct, time to completion 
Word- Number correct, time to completion 
 
 Continuous Performance Test- Identical Pairs  
d’ overall 
 
 Arithmetic subtest (WAIS-III)  
Standard score 
 
 Digit Span subtest (WAIS-III)  
Standard score 
 
Executive Functioning 
 
 Wisconsin Card Sorting Test  
% perseverative errors  
% nonperseverative errors, 
% conceptual level response 
  Categories completed  
 
Mazes subtest (WISC-III)  
Total number of errors 
  
Controlled Oral Word Association Test (CFL)  
Number of correct responses 
 
 Ruff Figural Fluency Test  
Trials 3 and 5- Total score  
Error ratio 
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Table 2 (continued) 
 
Memory 
 
California Verbal Learning Test- Second Edition (CVLT-II)  
Trial 1 
Long delay retention % change  
Long delay cued recall  
Proactive interference 
Retroactive interference 
Recognition discriminability  
Semantic clustering  
Serial clustering 
 
 Digit Span subtest (WAIS-III)  
Standard score 
 
 Brief Visuospatial Memory Test- Revised (BVMT-R)  
Trial 1  
Delay- % retained 
 
 Letter Number Sequencing subtest (WAIS-III)  
Standard score
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Table 3 
Correlation Coefficients for Measures of Attention, Executive Functioning, and Memory 
Attention 
 d’ AR SCC SCT SWC SWT DS TAT TBT CG 
d’ 1          
AR .24** 1         
SCC .09 .08 1        
SCT -.36** -.05 -.22** 1       
SWC .08 .06 .23** -.22** 1      
SWT -.34** -.09 -.14 .61** -.30** 1     
DS .33** .33** -.02 -.27** .19* -.28** 1    
TAT -.06 -.03 -.01 .24** .00 -.15 .03 1   
TBT -.14 -20* -.10 -.24** -.20* .35** -.15 .31** 1  
CG .20* .05 .09 -.43** .11 -.43** .08 -.28** -.40** 1 
MZ -.16* .20* .09 .10 .03 .03 -.19* -.08 .12 .05* 
VF .26* .15 .11 .24** .07 -.17* .32** .00 -.03 .06 
RF .19* .01 .16 .27** .15 -.20* .14 .30** -.21** .26** 
CC .14 .14 .04 .07 .23** -.09* .14 .02 -.09* -.05 
PP -.16 -.19* -.01 -.07 -.19* .05 -.18* -.05 -.02 .17* 
NP -.15 -.25** -.03 -.01 -.17* .10 -.07 .11 .14 .03 
CLR .17* .24** .03 .07 .17* -.07 .13 -.03 -.06 -.11 
ER -.18* -.12 -.07 .00 .03 .06 -.17* -.05 .05 .10 
CV1 .12 .10 -.09 -.15 .24 .20* .21* -.06 -.22** .27** 
DC .07 .15 .07 -.12 .14 -.18* .20* -.12 -.19* .26** 
DF .09 .12 .07 -.13 -.04 -.27* .13 -.07 -.06 .06 
SC -.02 .08 -.05 .02 .12 -.12 -.05 -.15 -.22 .20* 
SER .04 -.02 .07 -.04 .04 .03 .13 .19 .18 -.08 
PI .03 .12 .13 .07 -.13 .10 .09 .04 .05 -.04 
RI .04 .03 -.05 .13 .09 .11 .00 .08 -.02 .12 
RC .08 .13 .04 .09 .15 .01 .12 .05 -.18 .14 
BV1 .12 .02 .00 .01 .16* -.05 .12 -.12 -.25** .09 
BVD .09 .05 -.05 .05 .08 .04 .13 .10 .10 .17* 
LNS .34** .37** .10 -.25* .08 -.18 .60** -.06 -.18* .07 
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Table 3 (continued) 
 
d’=CPT, d’; AR=WAIS-III, Arithmetic; SCC=Stroop Color and Word Test, Color- Number Correct; 
SCT=Stroop Color and Word Test, Color- Time to Completion; SWC=Stroop Color and Word Test, Word- 
Number Correct; SWT=Stroop Color and Word Test, Word- Time to Completion; DS=WAIS-III, Digit 
Span; TAT=Trail Making Test, Part A- Time to Completion; TBT=Trail Making Test, Part B- Time to 
Completion; CG=WAIS-III, Coding 
 
Executive Functioning 
 MZ VF RF CC PP NP CLR ER 
MZ 1   
VF .01 1  
RF .14 .06 1 
CC -.01 .09 -.04 1
PP .02 -.09 .02 -.70** 1
NP -.12 -.03 -.02 -.61** .58** 1
CLR .07 .07 -.02 .76** -.84** -.89** 1
ER .16 -.12 .02 -.09 .11 .08 -.09 1
d’ -.16* ..26** .19* .14 -.16 -.16 .17* -.18* 
AR -.20* .15 .01 .14 -.19* -.25* .24** -.12 
SCC -.09 .11 .16 .04 .00 -.03 .03 -.07 
SCT .10 -.24** -.27** .07 -.08 -.01 .07 .00 
SWC .03 .07 .15 .23** -.19* -.17* .17* -.17* 
SWT .03 -.17* -.20* -.09 .06 .10 -.07 .06 
DS -.19* .32** .14 .14 -.18* -.07 .13 -.17* 
TAT -.08 .00 -.30** .02 -.05 .11 -.03 -.05 
TBT .12 -.03 -.21** -.09 -.02 .14 -.06 .05 
CG .05 .06 .26** -.05 .17* .03 -.11 .10 
CV1 -.10 .03 .05 .14 -.06 -.10 .09 .16 
DC .08 .03 .15 -.02 .03 -.03 .00 -.06 
DF -.06 .12 .04 .04 -.06 -.09 .06 -.09 
SC .03 .06 .06 .02 .04 -.09 .03 .06 
SER -.12 -.05 -.18* .06 -.08 -.02 .04 -.07 
PI .04 .12 -.03 -.01 .02 .02 .00 -.18* 
RI -.03 -.04 -.03 .02 -.01 .07 -.02 .10 
RC .02 .06 -.13 .13 .00 -.13 .08 -.03 
BV1 .02 .14 .10 .08 -.03 -.17* .10 -.05 
BVD -.10 .02 .15 .12 -.18* -.17* .19* -.14 
LNS -.23 .23** .06 .08 -.09 -.01 .06 -.15 
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Table 3 (continued) 
 
MZ=WISC-III, Mazes- Total Number of Errors; VF=Controlled Oral Word Association Test- Number of 
Correct Responses; RF=Ruff Figural Fluency Test, Trials 3 and 5- Total Score; CC= Wisconsin Card 
Sorting Test, Categories Completed; PP=Wisconsin Card Sorting Test, % Perseverative Errors; 
NP=Wisconsin Card Sorting Test, % Nonperseverative Errors; CLR=Wisconsin Card Sorting Test, % 
Conceptual Level Response; ER=Ruff Figural Fluency Test, Error Ratio 
 
Memory 
 CV1 DC DF SC SER PI RI RC BV1 BVD LNS 
CV1 1      
DC .22** 1     
DF -.12 .04 1    
SC .36** .17* -.01 1    
SER .11 -.04 -.07 -.70** 1    
PI -.54** -.01 .25** -.14 .07 1    
RI .23** .17* -.61** .20* -.02 -.18* 1    
RC .23** .36** -.19* .25** .04 .25** -.46** 1    
BV1 .15 .10 .01 .03 .02 .00 .07 .28** 1   
BVD -.08 .03 .09 -.12 .04 .10 -.03 -.01 .18* 1  
LNS .20* .14 .07 -.04 .11 .00 .06 .10 .12 .00 1 
MZ -.10 .08 -.06 .03 -.12 .04 -.03 .02 .02 -.10 -.23** 
VF .03 .03 .12 .06 -.05 .12 -.04 .06 .10 .02 .23** 
RF .05 .15 .04 .06 -.18* -.03 -.03 -.13 .08 .15 .06 
CC .14 -.02 .04 .02 .06 -.01 .02 .13 -.03 .12 .08 
PP -.06 .03 -.06 .04 -.08 .02 -.01 .00 -17* -.18* -.09 
NP -.10 -.03 -.09 -.09 -.02 .02 .07 -.13 .10 -.17* -.01 
CLR .09 -.01 .06 .03 .04 .00 -.02 .08 -.05 .19 .06
ER -.16 -.06 -.09 .06 -.07 -.18* .10 -.03 .13 -.14 -.15
d’ .13 .07 .09 -.02 .12 .03 .04 .08 .02 .24** .34**
AR .10 .15 .12 .08 -.02 .12 .03 .13 .00 .09 .37**
SCC -.09 .07 .03 -.05 .07 .13 -.05 .04 .01 -.07 .10
SCT .16 -.12 -.13 .02 -.04 .07 .13 .09 .16* .08 -.25**
SWC .24** .14 -.04 .12 .04 -.13 .09 .15 .16* .17* .08
SWT -.20* -.18* -.27** -.12 .03 .10 .11 .01 -.05 -.06 -.18*
DS -.21** .20* .13 -.05 .13 .09 .00 .12 .12 .18* .60**
TAT -.07 -.12 -.07 -.15 .19* .04 .08 .05 -.12 .03 -.06
TBT -.22 -.19* -.06 -.22** .18* .05 -.02 -.18* -.25** -.11 -.18*
CG .27** .26** .06 .20* -.08 -.04 .12 .14 .09 -.04 .07
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Table 3 (continued) 
 
 
CV1=CVLT-II, Trial 1; DC=CVLT-II, Long Delay Cued Recall;  DF=CVLT-II, Long Delay Retention % 
Change;  SC=CVLT-II, Semantic Clustering; SER=CVLT-II, Serial Clustering; PI=CVLT-II, Proactive 
Interference; RI= CVLT-II, Retroactive Interference; RC=CVLT-II, Recognition Discriminablity; 
BV1=BVMT-R, Trial 1; BD= BVMT-R, Delay- % Retained; LNS=WAIS-III, Letter Number Sequencing 
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Table 4 
Principal Components Analysis of Neuropsychological Variables with Promax Rotation 
Variables         Factors 
  1 2 3 4 5
WCST- % Perseverative Errors  -.855 -.047 -.194 .066 -.013
WCST- % Nonperseverative errors  -.857 .115 -.080 -.149 .049
WCST- % Conceptual Level Response .967 -.020 .138 .050 -.022
WCST- Categories Completed  .829 .009 .183 .066 .047
Stroop Color- Time to Completion  .046 .747 -.328 .050 .018
Stroop Word- Time to Completion  -.060 .722 -.299 -.134 .069
Trails A- Time to Completion  -.070 .539 .086 -.160 .051
Trails B- Time to Completion  -.100 .504 -.256 -.474 -.096
Digit Symbol Coding- Standard Score -.155 -.630 .062 .336 .085
RFFT- Total Number Correct- Trials 3 + 5 .014 -.543 .022 .088 .010
Digit Span- Standard Score     .179 -.194 .732 .080 .033
Arithmetic- Standard Score   .280 -.027 .519 .176 -.068
Letter Number Sequencing- Standard Score .108 -.197 .710 .053 .070
COWAT- Fluency Total Score  .067 -.136 .458 .147 -.152
CPT-IP- D prime (d’) Overall  .237 -.355 .540 .040 .058
Mazes- Total Number of Errors  .034 -.093 -.403 .066 -.089
CVLT-II- Total Recognition Score     .054 .185 .348 .586 .350
CVLT-II- Long Delay Cued Recall Total Score -.044 -.173 .262 .463 .095
CVLT-II- Semantic Clustering Raw Score .020 -.158 -.189 .774 .114
CVLT-II- Serial Clustering Raw Score .030 .172 .369 -.595 .117
BVMT-R- Trial 1 Raw Score    .150 -.160 .266 .421 .153
CVLT-II- Trial 1 Raw Score   .142 -.301 .122 .381 .640
CVLT-II- Proactive Interference  -.034 .234 .217 -.010 -.635
CVLT-II- Retroactive Interference  -.082 .312 .143 .325 .704
CVLT-II- Long Delay Retention % Change .154 -.308 .016 .002 -.687
RFFT- Error Ratio    -.119 -.114 -.370 -.055 .278
BVMT-R- Delayed Recall % Retained   .292 .096 .108 -.021 -.089
Stroop Color- Total Number Correct -.073 -.184 .272 -.060 -.157
Stroop Word- Total Number Correct  .190 -.219 .288 .241 .195
Variance Accounted for in Analysis 14.5% 11.4% 8.8% 7.5% 5.2%
 
Bolded values signify factor loadings > .400. 
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Table 5 
 
Correlation Coefficients of the Five Neuropsychological Factors 
 
 
 
Executive 
Functioning 
Processing 
Speed 
Sustained 
Attention 
Long Term 
Memory Interference 
Executive 
Functioning      
 
Processing Speed -.06     
 
Sustained 
Attention 
 .17* -.12    
 
Long Term 
Memory 
.07 -.15 .09   
 
Interference -.01 .04 .09 .18*  
 
 
* p < .05 
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Table 6 
 
Linear Regression Analysis for Neuropsychology Factors 
________________________________________________________________________ 
 
 
 Executive Functioning Processing Speed Sustained Attention 
 R ∆ R2 beta R ∆ R2 beta R ∆ R2 beta 
Brief Symptom Inventory-
Global Severity Index 
 
.100 .010 -.100 .012 .000  .012 .158 .025 .158 
Estimated IQ .177 .021 -.091 .200 .040* -.200 .450 .177*** .422 
Negative Schizotypy .177 .000  .001 .215 .006 -.084 .454 .004 .067 
Positive Schizotypy .246 .029* -.208 .215 .000 -.003 .492 .036** -.229 
Negative Schizotypy x 
Positive Schizotypy 
 
.254 .004  .067 .217 .001  .036 .495 .003 .060 
Negative Schizotypy x IQ .266 .006  .086 .219 .001  .029 .495 .001 .028 
Positive Schizotypy x IQ .266 .000 -.019 .227 .004  .064 .498 .003 -.054 
Negative x Positive 
Schizotypy x IQ 
 
.289 .013 -.137 .291 .033* -.223 .502 .004 -.080 
Total R2  .083   .085   .252***  
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Table 6 (continued) 
 
 
 Long Term 
Memory Interference 
 R ∆ R2 beta R ∆ R2 beta 
Brief Symptom Inventory-Global 
Severity Index 
 
.133 .018 -.133 .074 .006  .074 
Estimated IQ .304 .075***  .274 .096 .004 -.061 
Negative Schizotypy .304 .000 -.015 .098 .000  .018 
Positive Schizotypy .305 .000  .019 .194 .028*  .203 
Negative x Positive Schizotypy .313 .005 -.081 .198 .001 -.042 
Negative Schizotypy x IQ .332 .012 -.121 .198 .000  .017 
Positive Schizotypy x IQ .335 .002  .044 .214 .007 -.087 
Negative x Positive Schizotypy x IQ .344 .006  .097 .227 .006 -.091 
Total R2  .119*   .051  
 
________________________________________________________________________ 
 
*p < .05    **p < .01    ***p < .001 
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Table 7 
 
MATRICS Provisional Consensus Cognitive Battery  
 
 
Cognitive Domain and Tests 
Speed of Processing 
Category Fluency 
Brief Assessment of Cognition in Schizophrenia (BACS)- Symbol-Coding 
Trail Making Test- Part A 
Attention/Vigilance 
Continuous Performance Test– Identical Pairs (CPT-IP) 
Working Memory 
University of Maryland- Letter Number Span 
Wechsler Memory Scale- Third Edition (WMS-III)- Spatial Span 
Verbal Learning 
Hopkins Verbal Learning Test- Revised (HVLT-R) 
Visual Learning 
Brief Visuospatial Memory Test- Revised (BVMT-R) 
Reasoning and Problem Solving 
Neuropsychological Assessment Battery (NAB)- Mazes 
Social Cognition 
Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)- Managing 
 Emotions 
